Murine NK cell allospecificity-1 is defined by inhibitory ligands

Journal of Immunology

Volumn 156, Issue 12, 1996, Pages 4651-4655

  Zheng, Wei Ping ^a   Kiura, Katsuyuki ^a,c   Milisauskas, Vita K ^a   DeNardin, Ernesto ^b   Nakamura, Ichiro ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND;

ALLOGRAFT; ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; ENZYME SPECIFICITY; GENE MAPPING; GENETIC LINKAGE; GRAFT REJECTION; KILLER CELL; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECESSIVE INHERITANCE; REGULATOR GENE;

ANIMALS; FEMALE; H-2 ANTIGENS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LEUKEMIA L1210; LIGANDS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; TRANSFECTION;

EID: 0029992127     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ciccone, E., D. Pende, O. Viale, C. Di Donato., G. Tripodi, A. M. Orengo, J. Guardiola, A. Moretta, and L. Moretta. 1992. Evidence of a natural killer (NK) cell repertoire for (allo)antigen recognition: definition of five distinct NK-determined allospecificities in humans. J. Exp. Med. 175:709.
2. Suzuki, N., T. Suzuki, and E. G. Engleman. 1991. Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells. J. Exp. Med. 173:1451.
3. Vaage, J. T., E. Dissen, A. Ager, S. Fossum, and B. Rolstad. 1991. Allospecific recognition of hemic cells in vitro by natural killer cells from athymic rats: evidence that allodeterminants coded for by single major histocompatibility complex haplotypes are recognized. Eur. J. Immunol. 21:2167.
4. Chadwick, B. S., and R. G. Miller. 1992. Hybrid resistance in vitro: possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J. Immunol. 148:2307.
5. 1 hybrid NK cell subsets defined by Ly-49A expression. J. Immunol. 155: 2822.
6. Cudkowicz, G., and M. Bennett. 1971. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J. Exp. Med. 134:83.
7. Bennett, M. 1987. Biology and genetics of hybrid resistance. Adv. Immunol. 41:333.
8. Colonna, M., G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 90:12000.
9. Cella, M., A. Longo, G. B. Ferrara, J. L. Strominger, and M. Colonna. 1994. NK3-specific natural killer cells are selectively inhibited by Bw4-positive alleles with isoleucine 80. J. Exp. Med. 180:1235.
10. Moretta, A., M. Vitale, C. Bottino, A. M. Orengo, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Moretta. 1993. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells: anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178:597.
11. Lanier, L. L., J. E. Gumperz, P. Parham, I. Melero, M. Lopez-Botet, and J. H. Phillips. 1995. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J. Immunol. 154:3320.
12. Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319:675.
13. Vaage, J. T., C. Naper, G. Lvik, D. Lambracht, A. Rehm, H. J. Hedrich, K. Wonigeit, and B. Rolstad. 1994. Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens. J. Exp. Med 180:641.
14. Rembecki, R. M., M. Bennett, V. Kumar, and C. S. David. 1987. Hemopoietic histocompatibility (Hh-1) antigens: polymorphism and mapping. In H-2 Antigens. Genes, Molecules, Function. C. S. David, ed. Plenum Press, New York, p. 103.
15. Daley, J. P., J. M. Wroblewski, S. G. Kaminsky, and I. Nakamura. 1987. Genetic control of the target structures recognized in hybrid resistance. Immunogenetics 26:21.
16. Cudkowicz, G. 1968. Hybrid resistance to parental grafts of hematopoietic and lymphoma cells. In The Proliferation and Spread of Neoplastic Cells. E. Frei III, ed. Williams and Wilkins Co., Baltimore, pp. 661-691.
17. 1 hybrid lymphoma cells: evidence consistent with trans gene regulation. J. Immunol. 138:2734.
18. Yu, Y. Y. L., V. Kumar, and M. Bennett. 1992. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 10:189.
19. Öhlén, C., G. Kling, P. Höglund, M. Hansson, G. Scangos, C. Bieberich, G. Jay, and K. Kärre. 1989. Prevention of allogeneic marrow graft rejection by H-2 transgene in donor mice. Science 246:666.
20. Bennett, M. 1972. Rejection of marrow allografts: importance of H-2 homozygosity of donor cells. Transplantation 14:289.
21. d. Eur. J. Immunol. 24:336.
22. 2 domains. J. Immunol. 153:5482.
23. b/d cells. Mol. Immunol. 32:773.
24. Dexter, T. M., T. D. Allen, D. Scott, and N. M. Teich. 1979. Isolation and characterisation of a bipotential haematopoietic cell line. Nature 277:471.
25. d anti-gens on the surface of these cells. Transplantation 34:113.
26. b antibody. In The Immune System. Festschrift in Honor of Niels Kaj Jerne on the Occasion of his 70th Birthday, Vol. 2. C. M. Steinberg and I. Lefkovits, eds. Karger, Basel, p. 202.
27. Lemke, H., G. G. Hämmerling, and U. Hammerling. 1979. Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL. region in mice. Immunol. Rev. 47:175.
28. b bone marrow allograft. Eur. J. Immunol. 17:1043.
29. 1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors. J. Exp. Med. 159:1132.
30. Evans, G. A., D. H. Margulies, B. Shykind, J. G. Seidman, and K. Ozato. 1982. Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens. Nature 300:755.
31. d by natural killer cells. Nat. Immun. 14:67 (Abstr.).
32. Olsson, M. Y., K. Kärre, and C. L. Sentman. 1995. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc. Natl. Acad. Sci. USA 92:1649.
33. Mason, L. H., J. R. Ortaldo, H. A. Young, V. Kumar, M. Bennett, and S. K. Anderson. 1995. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). J. Exp. Med. 182:293.
34. 1 antiparent killing in vitro. J. Immunol. 154:1624.
35. Sentman, C. L., V. Kumar, G. Koo, and M. Bennett. 1989. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts. J. Immunol. 142:1847.
36. Cudkowicz, G., and G. B. Rossi. 1972. Hybrid resistance to parental DBA/2 grafts: independence from the H-2 locus. I. Studies with normal hematopoietic cells. J. Natl. Cancer Inst. 48:131.
37. 1 hybrid and allogeneic mice to bone marrow grafts of NZB donors. J. Immunol. 110:791.
38. r molecules expressed on bone marrow cells. Int. Immunol. 6:1297.
39. Stoneman, E. R., M. Bennett, J. An, K. A. Chesnut, E. K. Wakeland, J. B. Scheerer, M. J. Siciliano, V. Kumar, and P. A. Mathew. 1995. Cloning and characterization of 5E6 (Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J. Exp. Med. 182:305.
40. Moretta, A., S. Sivori, M. Vitale, D. Pende, L. Morelli, R. Augugliaro, C. Bottino, and L. Moretta. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182:875.